A new peptide-based nanotube treatment sneaks chemo into drug-resistant cancer cells, providing a unique workaround to one of oncology’s toughest hurdles.
CiQUS researchers have developed a novel molecular strategy that allows a chemotherapy drug to enter the nucleus of tumor cells and exert its therapeutic impact, even in drug-resistant cancers. Their findings were published in ACS Applied Materials and Interfaces.
The study focused on doxorubicin, a commonly used chemotherapy drug. Prolonged treatment with this drug frequently results in the formation of resistant cells, which causes substantial difficulties in clinical use that the new approach successfully addresses, while maintaining the drug’s antitumor efficacy.
The technique is based on a simple but powerful concept: cyclic peptides (small amino acid rings) can stack and self-assemble into hollow cylindrical structures (nanotubes) on the surface of cancer cell membranes.
The molecular-scale drug delivery, created by a team led by Juan R. Granja, binds doxorubicin to these peptides and transports it to the cell nucleus via a mechanism that bypasses common drug resistance pathways, such as efflux pumps. This enables the drug to circumvent the cellular resistance mechanisms that typically render it ineffective.
Cancer cell membranes contain more negatively charged lipids than healthy cells. The cyclic peptides used in this study have a high affinity for these anionic surfaces, facilitating their interaction with tumor cells. Consequently, the peptide-drug conjugates enter resistant cells and go to the nucleus, where doxorubicin intercalates with DNA to produce its cytotoxic impact.
Critically, the efficacy of this delivery method depends on the structure of the cyclic peptide, particularly the inclusion of hydrophobic alkyl chains of specific lengths. Experimental research indicated that the chemical structure of the cyclic peptide is critical for the creation of stable nanotubes, which improves their capacity to penetrate malignant cells.
Drug resistance remains one of the most significant challenges in cancer therapy. Many tumors evolve systems to actively evade drugs, significantly reducing the efficacy of existing treatments. In this situation, cyclic peptides serve as multifunctional delivery vehicles, both enhancing uptake and shielding the drug from premature expulsion from tumor cells, allowing doxorubicin to enter cells that would otherwise reject it.
This technique, which combines selectivity, effective transport, and controlled drug release, opens the door to novel combination chemotherapies in which peptide-based nanotechnology might be a potent ally against cancer. Laboratory studies showed that versions of the peptide with ten carbon alkyl tails were the most effective, both in penetrating drug-resistant ovarian cancer cells and delivering doxorubicin to the nucleus.
The scientists anticipate that this method could spur the development of novel treatment techniques for difficult-to-treat tumors.
Journal Reference:
Vilela-Picos, M. et.al. (2025). Self-Assembling Cyclic Peptide Nanotubes for the Delivery of Doxorubicin into Drug-Resistant Cancer Cells. ACS Applied Materials and Interfaces. doi.org/10.1021/acsami.5c05264.
News
Stanford’s Revolutionary New Microscope Reveals Living Cells in Stunning Detail
Stanford researchers have developed a microscope that can show how nanostructures interact inside living cells at the highest resolution achieved so far. The view into living cells just got better. Stanford researchers have merged [...]
What Bundibugyo Ebola vaccines and treatments are under development
By Mariam Sunny and Jennifer Rigby May 29 (Reuters) – Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic Republic of Congo, linked to the [...]
Why More People in Their 30s Are Suddenly Getting Colon Cancer
A major Swiss study found that colorectal cancer is becoming increasingly common in adults under 50, even as rates decline in older age groups. Researchers in Switzerland have identified a concerning trend: while colorectal [...]
Researchers Compare MS Models to Human Tissue in Search for Better Therapies
Researchers identified key differences between two widely used multiple sclerosis models, showing how each can better study myelin damage, immune responses, and repair. The findings may improve efforts to develop treatments that restore lost [...]
Scientists Discover Genetic “Off Switch” That Supercharges CAR T Cells Against Cancer
A new study reveals a possible way to make CAR T-cell therapy more durable and effective by targeting a single gene-regulating protein. CAR T-cell therapy is widely seen as a breakthrough in personalized cancer [...]
New Vitamin B12-Based Therapy Could Change How Brain Cancer Is Treated
Researchers have identified a vitamin B12–based compound that appears capable of crossing the blood–brain barrier and selectively accumulating in glioblastoma tissue. For decades, one of the biggest problems in brain cancer treatment has had [...]
Simple Fiber Supplement Cuts Knee Arthritis Pain in Just 6 Weeks, Study Finds
A daily inulin supplement may help reduce knee osteoarthritis pain while revealing a possible link between gut health, muscle function, and pain sensitivity. For millions of people living with knee osteoarthritis, managing chronic pain [...]
This Common Vitamin May Help Stop Prediabetes From Turning Into Diabetes
Vitamin D may help prevent type 2 diabetes in people with specific genetic variations, offering a possible path toward personalized diabetes prevention. More than 40% of U.S. adults have prediabetes, a condition in which [...]
Ebola, hantavirus: Is the world prepared for the next pandemic?
Funding cuts to health research and a growing antivaccine movement are making it harder than ever to respond to viruses. The World Health Organization (WHO) has declared that an Ebola outbreak in Uganda and [...]
May 2026 Healthcare News and Trends: Market Signals That Matter
Artificial intelligence is dominating headlines, telehealth has settled into a new normal, and digital health continues to promise transformation. However, much of what is being discussed in healthcare today reflects potential rather than reality. [...]
Scientists Rewire Donor Stem Cells To Outsmart Aggressive Blood Cancers
Researchers have tested a gene-edited stem cell transplant designed to shield healthy blood-forming cells from powerful cancer-targeting immunotherapies. For patients with highly aggressive blood cancers, stem cell transplantation can offer a rare chance at [...]
Recent Digital Health Trends, Insights and News – May 2026
Last month marked continued progress as digital health moves into its next phase — from AI expanding into drug discovery and core infrastructure to new federal pathways accelerating device access and home-based care. Together, [...]
Cancer Mystery Solved: Scientists Discover How Melanoma Becomes “Immortal”
Scientists have uncovered a previously overlooked mechanism that may help melanoma cells become effectively “immortal.” Cancer cells face a major problem before they can become deadly: They have to figure out how to stop [...]
How Visual Neurons Organize Thousands of Synaptic Inputs
Summary: A new study uncovered the organizational rules that determine how neurons in the primary visual cortex process information. By imaging both the cell bodies (soma) and the individual synapses (on dendritic spines) of [...]
Scientists Just Found a Surprising Way To Destroy “Forever Chemicals”
Scientists have uncovered a new mechanism that may help break down highly persistent PFAS pollutants. PFAS have earned the nickname “forever chemicals” for a reason. These industrial compounds are so chemically durable that they [...]
Scientists Discover Cheap Material That Kills Deadly Superbugs
A new sulfur-rich antimicrobial polymer shows strong effectiveness against fungal and bacterial pathogens and may offer an affordable solution to antimicrobial resistance. Antimicrobial resistance is creating growing challenges for both healthcare and food production, [...]
